While numerous large pharmaceutical companies and biotech firms have come forward and assisted global endeavours to uncover a Covid-19 vaccine, research teams at the University of Oxford have also placed themselves firmly at the forefront of these ongoing efforts.
Not only is it developing and testing its own vaccine candidate — which pharma giant AstraZeneca has already agreed to manufacture, and distribute, once it passes clinical testing — but it’s now heavily involved in the hunt for an effective coronavirus treatment too.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
We take a closer look at how the world’s second-oldest university is contributing to the global fight against Covid-19 on multiple fronts.
